Pricing Log in Create free account

Addex Therapeutics Ltd. Sponsored ADR (ADXN) vs Lipella Pharmaceuticals Inc. (LIPO)

Addex Therapeutics Ltd. Sponsored ADR and Lipella Pharmaceuticals Inc. are both Biotechnology companies. Lipella Pharmaceuticals Inc. is the larger, with a market value of $3.4M against $3.1M — 1.1× the size. Lipella Pharmaceuticals Inc. grew revenue faster over the last twelve months: −7.29% against −75.8%. Across the 12 metrics below, Lipella Pharmaceuticals Inc. leads on 10 and Addex Therapeutics Ltd. Sponsored ADR on 2.

Valuation

Metric ADXN LIPO Biotechnology median
P/E n/m n/m 10.60
P/S 12.90 n/m 9.40
P/B 1.23 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.29 0.66
EV/Sales 8.67 (3.31) 9.02
Earnings yield (302.94%) 0.00% (32.88%)
Free cash flow yield (99.60%) 0.00% (23.13%)

Profitability

Metric ADXN LIPO Biotechnology median
Gross margin 43.88% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (154.91%) (361.77%) (51.96%)
Return on assets (117.46%) (236.36%) (46.06%)
Return on invested capital (141.24%) 0.00% 0.00%

Growth

Metric ADXN LIPO Biotechnology median
Revenue growth (TTM) (75.77%) (7.29%) 6.76%
EPS growth (last fiscal year) (191.09%) 22.24% 29.88%
Revenue growth, 5-year CAGR (60.68%) (5.04%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADXN LIPO Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.76 3.24 4.97
Net debt to EBITDA 0.58 0.43 1.01

Dividend

Metric ADXN LIPO Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ADXN LIPO Biotechnology median
Market cap 3.07m 3.39m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack